Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 122.81
   
  • Change Today:
    $4.96
  • 52 Week High: $124.11
  • 52 Week Low: $86.29
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 15,845,861
  • Market Cap: $153,021m
  • RiskGrade: 120

Latest ShareCast News

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Gilead raises 2020 forecasts after Covid-19 surge boosts remdesivir

By Abigail Townsend

Date: Monday 11 Jan 2021

(Sharecast News) - Gilead Sciences has upped its full-year profit guidance following strong sales of its Covid-19 treatment remdesivir.

FDA grants EUA for Eli Lilly treatment in conjunction with Remdesivir

By Alexander Bueso

Date: Friday 20 Nov 2020

(Sharecast News) - The Food and Drug Administration has granted Emergency Use Approval for baricitinib, a treatment for Covid-19 developed jointly by Eli Lilly and Incyte, in combination with Gilead Sciences's remdesivir.

WHO advises against prescribing remdesivir for C... 20-Nov-2020 ShareCast
Eli Lilly halts late stage trial into Covid-19 a... 27-Oct-2020 ShareCast
FDA grants full approval to Gilead Sciences's Ve... 23-Oct-2020 ShareCast
Gilead Sciences's Remdesivir may cut Covid-19 ri... 10-Jul-2020 ShareCast
Single course of Covid-19 treatment to cost $2,3... 29-Jun-2020 ShareCast
Gilead Sciences to test inhaled version of Covid... 22-Jun-2020 ShareCast
JP Morgan stays at overweight on AstraZeneca fol... 08-Jun-2020 ShareCast
AstraZeneca approached Gilead about merger - rep... 08-Jun-2020 ShareCast
Sunday newspaper round-up: Pandemic, Jobs, Astra... 07-Jun-2020 ShareCast
Japan approves Gilead Sciences's Remdesivir for ... 07-May-2020 ShareCast
Top US expert hails 'quite good news' on Gilead ... 29-Apr-2020 ShareCast
Gilead Sciences shares halted after 'positive da... 29-Apr-2020 ShareCast
RBC Capital labels news on Gilead Science's Remd... 17-Apr-2020 ShareCast
Europe midday: Stocks snap back amid optimism fo... 17-Apr-2020 ShareCast
Gilead treatment has positive results on Covid-1... 17-Apr-2020 ShareCast
Gilead Sciences acquires immuno-oncology firm Fo... 02-Mar-2020 ShareCast
GSK and Gilead Sciences join race to find corona... 03-Feb-2020 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 122.81
Change Today $ 4.96
% Change 4.21 %
52 Week High $124.11
52 Week Low $86.29
Volume 15,845,861
Shares Issued 1,246.00m
Market Cap $153,021m
RiskGrade 120

What The Brokers Say

Strong Buy 9
Buy 12
Neutral 6
Sell 1
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 17-Oct-2025

Time Volume / Share Price
16:00 3,466,342 @ $122.81
15:59 100 @ $122.84
15:59 862 @ $122.81
15:59 100 @ $122.82
15:59 100 @ $122.82

Top of Page